Clinical Trials Browser

Phase 2/3 × Celecoxib × Genitourinary × Clear all

NCT00268476 2023-04-18

STAMPEDE

Phase 2/3 Active not recruiting

11,992 enrolled

Prostatic Neoplasms

NCT00006124 2013-02-13

Celecoxib in Treating Patients With Bladder Cancer

Phase 2/3 Completed

Urinary Bladder Neoplasms

NCT00136487 2009-12-09

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer

Phase 2/3 Completed

Prostatic Neoplasms